Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Tolvaptan in Acute Decompensated Heart Failure With Fluid Retention
ChiCTR2500103241Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tolvaptan in Acute Heart Failure (AHF) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Change in body weight from baseline to day 8. Started May 2025; status: recruiting.
02
Drugs
tolvaptan
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR2500103241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103241.